Hamid Namini
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Epidemiology top 5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
-
- Hepatitis B Virus Studies 8
- Oncology 7
- CAR-T cell therapy research 5
- Co-authors
- Michael S. Conte (2 shared papers)Gregory L. Moneta (2 shared papers)Alexander W. Clowes (2 shared papers)Lynn Seely (2 shared papers)Dennis F. Bandyk (2 shared papers)Michael Belkin (1 shared paper)Richard J. DeMasi (1 shared paper)Todd J. Lorenz (1 shared paper)
- Journals
- Journal of Hepatology (5 papers)Cancer Research (3 papers)Vaccine (3 papers)Journal of Biopharmaceutical Statistics (2 papers)Journal of Vascular Surgery (2 papers)
- Partner nations
- United StatesGermanyPhilippines
In The Last Decade
Hamid Namini
22 papers receiving 1.1k citations
Hamid Namini's Hit Papers
Peers
Comparison fields: 5 of 71
- Hepatology 248
- Epidemiology 412
- Surgery 449
- Infectious Diseases 107
- Internal Medicine 19
Countries citing papers authored by Hamid Namini
This map shows the geographic impact of Hamid Namini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Namini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Namini more than expected).
Fields of papers citing papers by Hamid Namini
This network shows the impact of papers produced by Hamid Namini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Namini. The network helps show where Hamid Namini may publish in the future.
Co-authors
The 25 scholars most cited alongside Hamid Namini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery Hit paper breakdown → | 2006 | 485 |
| 2 | 2001 | 221 | |
| 3 | 2005 | 114 | |
| 4 | 2013 | 91 | |
| 5 | 2020 | 61 | |
| 6 | 2013 | 61 | |
| 7 | 2012 | 55 | |
| 8 | 2022 | 12 | |
| 9 | 2002 | 12 | |
| 10 | 1996 | 11 | |
| 11 | 2002 | 11 | |
| 12 | 2002 | 10 | |
| 13 | 2018 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2019 | 4 | |
| 16 | 2013 | 2 | |
| 17 | 2001 | 2 | |
| 18 | 1996 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2019 | 1 |
About Hamid Namini
Hamid Namini is a scholar working on Epidemiology, Oncology, Hepatology, Immunology and Hematology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (8 papers), CAR-T cell therapy research (5 papers), Hepatitis C virus research (4 papers), Multiple Myeloma Research and Treatments (3 papers), Hepatitis Viruses Studies and Epidemiology (2 papers), Immunotherapy and Immune Responses (2 papers), Statistical Methods in Clinical Trials (2 papers) and Peripheral Artery Disease Management (2 papers). The work is most often cited by research in Hepatology (248 citations), Epidemiology (412 citations), Surgery (449 citations), Infectious Diseases (107 citations) and Internal Medicine (19 citations). Hamid Namini has collaborated with scholars based in United States, Germany and Philippines. Frequent co-authors include Michael S. Conte, Gregory L. Moneta, Alexander W. Clowes, Lynn Seely, Dennis F. Bandyk, Michael Belkin, Richard J. DeMasi, Todd J. Lorenz, Sean P. Roddy and Scott A. Berceli. Their work appears in journals such as Journal of Hepatology, Cancer Research, Vaccine, Journal of Biopharmaceutical Statistics and Journal of Vascular Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.